<div class="content-wrapper slide61 itemStates">
    <h1><a href="#">Improved CV Protection with Xarelto<sup>&reg;</sup>.<br/>More Patient Benefits</a></h1>
    <p>Active treatment with once-daily Xarelto vs warfarin in AF patients</p>
    
   <div class="hideElem" style="height: 420px;">
    <p><em>Significantly reduces <em>overall CV outcomes</em>.<br/><span>(composite of stroke, systemic embolism, MI, and vascular death)<sup>12</sup></span></em></p>
        <div class="module" style="width: 559px; height: 309px; left: 210px; background-image: url(content/images/efficacy/graph.png)">
    		<div class="legend">EVENT RATE PER<br/>100 PT-YRS</div>		
    		<ul class="pillars">
    			<li class="brown">
    				<div class="pillar">
    					<img src="content/images/efficacy/pillar-brown.png" alt="">
    				</div>
    			</li>
    			<li class="magenta">
    				<div class="pillar">
    					<img src="content/images/efficacy/pillar-magenta.png" alt="">
    				</div>
    			</li>
    		</ul>
    		<img src="content/images/efficacy/drop-arrow.png" alt="" class="dropArrow"/>
    	</div>                     
    </div>                      
    
    <div class="hideElem" style="height: 420px;">
    	<p><em>Patients on Xarelto experienced numerically<br />fewer CV events vs warfarin<sup>12</sup></em></p>				           
        <dl class="diamonds">
			<dt>MI</dt>
			<dd><p><em>Xarelto (0.91) vs<br /> warfarin (1.12)<sup>12</sup></em></p></dd>
			<dt>VASCULAR<br />DEATH</dt>
			<dd><p><em>Xarelto (1.53) vs<br /> warfarin (1.71)<sup>12</sup></em></p></dd>
		</dl>
    </div>
    
	<div class="ref2">
        <p>All values are expressed as event rate per 100 patient-years<br/> and are
         from the pre-specified, on-treatment analysis in the <br/>safety population</p>
    </div> 	   						    
	<ul class="dLinks">
          <li class="dLink1">Overall CV <br /> Outcomes</li>
          <li class="dLink2">MI and <br />Vascular Death</li>
      </ul>
</div>						